Meridian Bioscience (VIVO) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Craig-Hallum Downgrades Meridian Biosciences (VIVO) to Hold
November 14, 2016 12:53 PM ESTCraig-Hallum downgraded Meridian Biosciences (NASDAQ: VIVO) from Buy to Hold.
For an analyst ratings summary and ratings history on Meridian Biosciences click here. For more ratings news on Meridian Biosciences click here.
Shares of Meridian Biosciences closed at $17.40 yesterday.
... MoreMeridian Bioscience (VIVO) Declares $0.20 Quarterly Dividend; 4.7% Yield
November 10, 2016 7:48 AM ESTMeridian Bioscience (NASDAQ: VIVO) declared a quarterly dividend of $0.20 per share, or $0.8 annualized.
The dividend will be payable on December 1, 2016, to stockholders of record on November 21, 2016, with an ex-dividend date of November 17, 2016.
The annual yield on the dividend is 4.7 percent.
For... More
